| GTO ID | GTC1437 |
| Trial ID | NCT01716364 |
| Disease | Myelodysplastic Syndrome | Multiple Myeloma | Acute Myeloid Leukemia |
| Altered gene | LeY |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LeY CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome |
| Year | 2010 |
| Country | Australia |
| Company sponsor | Peter MacCallum Cancer Centre, Australia |
| Other ID(s) | LeYPh1 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||